Moreover, 40–85% of BC patients presented hypermethylation of the ESR1 gene [18] that highly correlated with ER-negative/progesterone receptor (PR) negative conditions, suggesting that ESR1 methylation status strongly contributes to tumor phenotypes [19]. Here, ESR1 is linked to neoplasm.